Current evidence and future perspectives about the role of iXip® in the diagnosis of prostate cancer-Reference-Cited by-同舟云学术

Current evidence and future perspectives about the role of iXip® in the diagnosis of prostate cancer

Published:2019-05 Issue:3 Volume:71 Page:
ISSN:0393-2249
Container-title:Minerva Urologica e Nefrologica
language:
Short-container-title:Minerva Urol Nefrol

Author:

Antonelli Alessandro,Francavilla Simone,Gallotta Andrea,Da Pozzo Luigi F.,Ferretti Stefania,Sigala Sandra,Simeone Claudio,Mirone Vincenzo,Artibani Walter,Porreca Angelo

Publisher

Edizioni Minerva Medica

Subject

Urology,Nephrology

Link

https://www.minervamedica.it/pdf.php?cod=R19Y2019N03A0201

Reference38 articles.

1. Cancer statistics, 2017

2. Associazione Italiana di Oncologia Medica. Linee guida 2017 - Carcinoma della prostata; 2017 [Internet]. Available from: http://media.aiom.it/userfiles/files/doc/LG/2017_LGAIOM_Prostata.pdf [cited 2019, Apr 17].

3. Biological bases of radical prostatectomy in the management of prostate cancer patients with oligometastatic disease

4. Screening and prostate cancer mortality: results of the European Randomised Study of Screening for Prostate Cancer (ERSPC) at 13 years of follow-up

5. European Association of Urology. Guidelines - Prostate cancer; 2019 [Internet]. Available from: https://uroweb.org/guideline/prostate-cancer/#1_4 [cited 2019, Apr 17].

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Correlation Between iXip and Final Pathology in Patients Affected by Prostate Cancer Undergoing Radical Prostatectomy: A Multicenter Prospective Trial (PROXIMA—PROstate iXip Index Multicenter Analysis);Frontiers in Urology;2022-01-21

2. The role of immune PSA complex (iXip) in the prediction of prostate cancer;Biomarkers;2020-11-23

3. Minimally invasive strategies for the treatment of prostate cancer recurrence after radiation therapy: a systematic review;Minerva Urologica e Nefrologica;2020-11